Copyright
©The Author(s) 2016.
World J Gastrointest Endosc. Dec 16, 2016; 8(20): 763-769
Published online Dec 16, 2016. doi: 10.4253/wjge.v8.i20.763
Published online Dec 16, 2016. doi: 10.4253/wjge.v8.i20.763
Table 2 Recurrence rates of esophageal adenocarcinoma by investigated risk factors of esophageal adenocarcinoma (n = 32) n (%)
| Variable | Recurrence rates | P value |
| EMR method | ||
| Cap | 4/8 (50) | 0.18 |
| Band | 5/24 (21) | |
| Pathology depth | ||
| sm1 | 3/11 (27) | 0.11 |
| sm2/3 | 6/21 (29) | |
| Tumor location | ||
| Proximal 2/3 esophagus | 2/4 (50) | 0.56 |
| Distal 1/3 esophagus | 7/28 (25) | |
| LPI | ||
| Yes | 0/2 (0) | 1.00 |
| No | 9/30 (30) | |
| Differentiation | ||
| Well-moderate | 8/27 (30) | 1.00 |
| Poor | 1/5 (20) | |
| Deep EMR margins | ||
| Positive | 4/16 (25) | 1.00 |
| Negative | 5/16 (31) | |
| Lateral EMR margins | ||
| Positive | 6/22 (27) | 1.00 |
| Negative | 3/10 (30) | |
| Primary treatment | ||
| Endoscopic +/- CRT | 7/25 (28) | 1.00 |
| Surgical | 2/7 (29) | |
- Citation: Ballard DD, Choksi N, Lin J, Choi EY, Elmunzer BJ, Appelman H, Rex DK, Fatima H, Kessler W, DeWitt JM. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc 2016; 8(20): 763-769
- URL: https://www.wjgnet.com/1948-5190/full/v8/i20/763.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i20.763